March 27 (Reuters) - The U.S. Food and Drug
Administration approved Akebia Therapeutics' ( AKBA ) drug to
treat anemia caused by chronic kidney disease in dialysis
patients, the drugmaker said on Wednesday.
(Reporting by Pratik Jain, Vaibhav Sadhamta and Mrinmay Dey in
Bengaluru; Editing by Subhranshu Sahu)